Top Markets
Coin of the day
Omnimmune Holdings, Inc. Omnimmune Holdings, Inc.

Omnimmune Holdings, Inc.

OMMH
株式のランク #42527
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as... Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.
株価
$0.0001
最終同期: 2026-07-17
時価総額
$981.00
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Omnimmune Holdings, Inc. (OMMH)

カテゴリー

Omnimmune Holdings, Inc.(OMMH)の配当利回りの履歴
Omnimmune Holdings, Inc.(銘柄コード: OMMH)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Omnimmune Holdings, Inc.(OMMH)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)